Healthcare provider profile · identity verified

Todd A Holcomb, M.D.

Internal Medicine · WACONIA, MN · NPI 1184703951

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	655	172
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	362	104
Omeprazole	Omeprazole	356	96
Simvastatin	Simvastatin	334	87
Levothyroxine Sodium	Levothyroxine Sodium	319	77
Rosuvastatin Calcium	Rosuvastatin Calcium	300	90
Lisinopril	Lisinopril	290	86
Amlodipine Besylate	Amlodipine Besylate	287	91
Trazodone Hcl	Trazodone Hcl	278	65
Tamsulosin Hcl	Tamsulosin Hcl	273	70
Losartan Potassium	Losartan Potassium	263	77
Pantoprazole Sodium	Pantoprazole Sodium	229	60
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	223	66
Escitalopram Oxalate	Escitalopram Oxalate	216	48
Allopurinol	Allopurinol	208	53
Metformin Hcl Er	Metformin Hcl	200	49
Gabapentin	Gabapentin	198	43
Spironolactone	Spironolactone	191	46
Hydrochlorothiazide	Hydrochlorothiazide	190	60
Celecoxib	Celecoxib	184	36
Metoprolol Succinate	Metoprolol Succinate	172	51
Carvedilol	Carvedilol	167	37
Eliquis	Apixaban	161	33
Sertraline Hcl	Sertraline Hcl	160	34
Mirtazapine	Mirtazapine	148	36
Finasteride	Finasteride	145	27
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	130	32
Furosemide	Furosemide	129	40
Tramadol Hcl	Tramadol Hcl	121	35
Montelukast Sodium	Montelukast Sodium	117	29
Glipizide	Glipizide	115	18
Labetalol Hcl	Labetalol Hcl	111	32
Memantine Hcl	Memantine Hcl	108	12
Pioglitazone Hcl	Pioglitazone Hcl	108	22
Metoprolol Tartrate	Metoprolol Tartrate	105	29
Warfarin Sodium	Warfarin Sodium	103	30
Lorazepam	Lorazepam	100	28
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	100	26
Prednisone	Prednisone	99	47
Atenolol	Atenolol	91	26
Zolpidem Tartrate	Zolpidem Tartrate	91	26
Citalopram Hbr	Citalopram Hydrobromide	86	23
Clopidogrel	Clopidogrel Bisulfate	79	23
Ezetimibe	Ezetimibe	77	24
Pravastatin Sodium	Pravastatin Sodium	74	20
Fluticasone Propionate	Fluticasone Propionate	72	28
Jardiance	Empagliflozin	72	17
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	72	25
Valsartan	Valsartan	71	26
Glipizide-Metformin	Glipizide/Metformin Hcl	69	20
Albuterol Sulfate Hfa	Albuterol Sulfate	66	24
Torsemide	Torsemide	66	20
Ketoconazole	Ketoconazole	65	18
Famotidine	Famotidine	64	13
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	64	20
Metformin Hcl	Metformin Hcl	62	17
Alendronate Sodium	Alendronate Sodium	60	16
Amitriptyline Hcl	Amitriptyline Hcl	56	13
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	56	14
Nortriptyline Hcl	Nortriptyline Hcl	56	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	54	23
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	50	50
Potassium Chloride	Potassium Chloride	49	suppressed
Ipratropium Bromide	Ipratropium Bromide	47	suppressed
Xarelto	Rivaroxaban	47	13
Azithromycin	Azithromycin	45	35
Glipizide Er	Glipizide	44	13
Minoxidil	Minoxidil	42	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	41	11
Bupropion Xl	Bupropion Hcl	39	11
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	38	suppressed
Methenamine Hippurate	Methenamine Hippurate	38	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	37	suppressed
Valacyclovir	Valacyclovir Hcl	37	16
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	36	suppressed
Duloxetine Hcl	Duloxetine Hcl	36	12
Fluoxetine Hcl	Fluoxetine Hcl	36	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	35	11
Clonazepam	Clonazepam	34	suppressed
Donepezil Hcl	Donepezil Hcl	34	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	34	suppressed
Pregabalin	Pregabalin	34	11
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	33	33
Midodrine Hcl	Midodrine Hcl	33	suppressed
Ropinirole Hcl	Ropinirole Hcl	32	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	31	suppressed
Tizanidine Hcl	Tizanidine Hcl	31	11
Azelastine Hcl	Azelastine Hcl	29	suppressed
Eszopiclone	Eszopiclone	29	suppressed
Hydralazine Hcl	Hydralazine Hcl	29	suppressed
Januvia	Sitagliptin Phosphate	28	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	28	15
Amoxicillin	Amoxicillin	27	19
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	27	suppressed
Rivastigmine	Rivastigmine Tartrate	26	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	26	17
Farxiga	Dapagliflozin Propanediol	25	suppressed
Nitroglycerin	Nitroglycerin	25	21
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	25	suppressed
Diazepam	Diazepam	24	suppressed
Methylprednisolone	Methylprednisolone	24	21
Cefuroxime	Cefuroxime Axetil	23	23
Sotalol	Sotalol Hcl	23	suppressed
Amiodarone Hcl	Amiodarone Hcl	22	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	22	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	21	18
Ventolin Hfa	Albuterol Sulfate	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Nuplazid	Pimavanserin Tartrate	19	suppressed
Ondansetron Odt	Ondansetron	19	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	19	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	19	suppressed
Alcohol Swabs	Alcohol Antiseptic Pads	17	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	17	suppressed
Cefadroxil	Cefadroxil	17	16
Clobetasol Propionate	Clobetasol Propionate	17	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	17	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	17	suppressed
Cholestyramine Light	Cholestyramine	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Terazosin Hcl	Terazosin Hcl	16	suppressed
Trospium Chloride	Trospium Chloride	16	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Alprazolam	Alprazolam	15	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	15	suppressed
Hydrocortisone	Hydrocortisone	15	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Pilocarpine Hcl	Pilocarpine Hcl	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	11
Humalog Kwikpen U-100	Insulin Lispro	14	suppressed
Mesalamine	Mesalamine	14	suppressed
Oxycodone Hcl	Oxycodone Hcl	14	12
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Temazepam	Temazepam	14	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	14	suppressed
Clonidine	Clonidine	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Propranolol Hcl Er	Propranolol Hcl	13	suppressed
Colestipol Hcl	Colestipol Hcl	12	suppressed
Digoxin	Digoxin	12	suppressed
Dilt-Xr	Diltiazem Hcl	12	suppressed
Nystatin	Nystatin	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Anastrozole	Anastrozole	11	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error